UMiami Health Talk: Disruptors of the Obesity Epidemic

During this UMiami Health Talk we heard from a panel of esteemed medical, business and pharmaceutical experts. They discussed various pivotal topics as they related to obesity disruptors, including: The far-reaching societal and economic impacts of the epidemic, challenges pertaining to access, obtaining medication and the extended effects of glp-1 drugs, nuances of physician bias against anti-obesity prescriptions, the impact of bariatric surgery on employment and psychological well-being, societal perceptions surrounding surgical interventions, the reluctance surrounding insurance coverage for obesity treatment, incretin therapy and its relation to addictive behaviors and future developments in this transformative field.